Finance

Lists
544292:BOM
Onesource Specialty Pharma Ltd
1 381,05 INR
-1,96%
(-27,65) 1D
19 ოქტ, 14:14:06 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544292...
Open
1 404,15 INR
High
1 413,35 INR
Low
1 377,95 INR
Mkt. cap
158,32 მლრ.
Avg. vol.
45,04 ათ.
Volume
116,05 ათ.
52-wk high
1 924,00 INR
52-wk low
1 075,00 INR
EPS
-4,25 INR
No. of employees
2 ათ.
Open
1 404,15 INR
High
1 413,35 INR
Low
1 377,95 INR
Mkt. cap
158,32 მლრ.
Avg. vol.
45,04 ათ.
Volume
116,05 ათ.
52-wk high
1 924,00 INR
52-wk low
1 075,00 INR
EPS
-4,25 INR
No. of employees
2 ათ.
News stories
From web sources and news partners
About Onesource Specialty Pharma Ltd
CEO-
Employees1,67 ათ.
Founded2007
Headquarters-
SectorHealth care
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,76 მლრდ.
2,90 მლრდ.
4,30 მლრდ.
4,49 მლრდ.
Cost of goods sold
1,13 მლრდ.
943,66 მლნ.
2,35 მლრდ.
1,42 მლრდ.
Cost of revenue
1,13 მლრდ.
943,66 მლნ.
2,35 მლრდ.
1,42 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
628,21 მლნ.
641,92 მლნ.
749,51 მლნ.
686,80 მლნ.
Operating expense
2,26 მლრდ.
2,48 მლრდ.
2,04 მლრდ.
2,55 მლრდ.
Total operating expenses
3,39 მლრდ.
3,43 მლრდ.
4,39 მლრდ.
3,97 მლრდ.
Operating income
366,68 მლნ.
-523,15 მლნ.
-87,15 მლნ.
516,01 მლნ.
Other non operating income
30,36 მლნ.
46,25 მლნ.
-229,61 მლნ.
38,02 მლნ.
EBT including unusual items
57,41 მლნ.
-930,11 მლნ.
-2,92 მლნ.
202,94 მლნ.
EBT excluding unusual items
57,41 მლნ.
-859,21 მლნ.
-4,48 მლნ.
245,94 მლნ.
Income tax expense
-47,44 მლნ.
-43,12 მლნ.
-48,89 მლნ.
-47,03 მლნ.
Effective tax rate
-82,63%
4,64%
1 674,32%
-23,17%
Other operating expenses
929,57 მლნ.
1,14 მლრდ.
572,91 მლნ.
1,15 მლრდ.
Net income
104,85 მლნ.
-886,99 მლნ.
45,97 მლნ.
249,97 მლნ.
Net profit margin
2,79%
-30,55%
1,07%
5,57%
Earnings per share
-
-7,15
-
2,56
Interest and investment income
-
-
115,54 მლნ.
-
Interest expense
-339,63 მლნ.
-382,31 მლნ.
-117,67 მლნ.
-308,09 მლნ.
Net interest expenses
-339,63 მლნ.
-382,31 მლნ.
-2,13 მლნ.
-308,09 მლნ.
Depreciation and amortization charges
698,27 მლნ.
696,37 მლნ.
718,26 მლნ.
717,46 მლნ.
EBITDA
1,05 მლრდ.
92,24 მლნ.
540,71 მლნ.
1,21 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები